Atlas Arteria’s Independent Directors maintain a unanimous rejection of IFM’s $5.10 per security takeover bid, citing undervaluation and insufficient control premium. The company reiterates its 2026 distribution guidance and confirms active asset sale discussions, including Chicago Skyway.
- Independent Directors recommend rejecting IFM’s $5.10 offer
- Offer price 12% below Independent Expert’s valuation midpoint
- 2026 distribution guidance reaffirmed at 40.0 cents per security
- Asset sales, including Chicago Skyway stake, progressing
- IFM’s history shows potential for higher future offers
Atlas Arteria Rejects IFM’s Takeover Bid as Undervalued
Atlas Arteria (ASX:ALX) has lodged its third supplementary target’s statement, reinforcing its Independent Directors’ unanimous recommendation that securityholders reject the unsolicited $5.10 per security takeover offer from Diamond Infraco 1 Pty Ltd, a subsidiary of IFM Global Infrastructure Fund. The directors argue the offer significantly undervalues the company, falling 12% below the midpoint of an Independent Expert’s valuation range of $5.39 to $6.20.
Despite IFM’s bid representing a modest premium to recent trading prices; circa 3% over the 12-month volume-weighted average price and 18% over the undisturbed price; the offer lacks an appropriate control premium typically expected in such transactions. The Independent Directors urge securityholders to simply ignore all documents from the Bidder and to reject the offer outright.
Distribution Guidance and Potential for Additional Returns
Atlas Arteria reaffirmed its ordinary distribution guidance of 40.0 cents per security for 2026, maintaining this target despite the ongoing takeover bid. The company also highlighted that any net proceeds from asset sales would be returned to securityholders in addition to this distribution guidance, potentially enhancing returns for those who reject the offer.
The Bidder has waived its previous condition prohibiting distributions during the offer period, and Atlas Arteria reserves the right to accelerate payment of part or all of its 2026 distributions. This move could increase the total value available to securityholders beyond the current offer price.
Progress on Asset Sales Including Chicago Skyway
Atlas Arteria confirmed it is actively progressing the sale of all or part of its 66.67% stake in the Chicago Skyway toll road, targeting agreement signings in the fourth quarter of 2026. The company is also exploring potential divestments of other majority and wholly owned assets. Net proceeds from these sales would be distributed to securityholders, representing additional value beyond the offer price and distributions guidance.
Addressing concerns raised by the Bidder about potential tax liabilities from a Chicago Skyway sale, Atlas Arteria stated it expects any tax costs to be immaterial and believes options exist to return proceeds to securityholders with minimal tax leakage.
IFM’s Track Record Suggests Room for Offer Improvement
While the current offer is firm at $5.10, Atlas Arteria pointed to IFM’s history of increasing offer prices in prior public market transactions. Examples include a 37% increase in its Aleatica tender offer price over several years, a 70% uplift in its Vienna Airport partial offer, and a 6% rise in its Sydney Airport acquisition price. This precedent suggests IFM may yet increase its offer, especially given the Director Representation Agreement in place that commits IFM to maintaining governance standards, including independent board chairs and a majority of independent directors.
Governance and Market Dynamics Amid Offer Uncertainty
The Director Representation Agreement continues to bind IFM regardless of its stake size, ensuring Atlas Arteria’s compliance with ASX Corporate Governance Council principles. Meanwhile, the Bidder’s ability to acquire securities on-market has introduced complexities such as stock borrowing and short selling, which Atlas Arteria warns could affect voting power dynamics. The company reserves rights to challenge any irregularities through the Takeovers Panel.
The offer period is scheduled to close at 7:00pm Sydney time on 25 June 2026, with securityholders to be informed at least seven days prior whether conditions have been met or if the period will be extended. If IFM’s voting power surpasses 50% in the final week, the offer period will automatically extend by 14 days, giving securityholders additional time to assess their position.
Bottom Line?
Atlas Arteria’s firm rejection and ongoing asset sale plans set the stage for a potentially higher offer or prolonged takeover battle.
Questions in the middle?
- Will IFM increase its offer price given Atlas Arteria’s firm stance and asset sale progress?
- How will potential tax implications shape the net returns from asset disposals like Chicago Skyway?
- Could market dynamics around stock borrowing and short selling influence the bid’s outcome?